Voedingsdilemma's voor de chronische nierpatiënt

De nieren verwijderen afvalstoffen en bepalen de mineraalbalans. Nierdisfunctie heeft een grote impact op het lichaam, in zoverre zelfs dat patiënten niet zozeer aan nierdisfunctie ten onder gaan, wel aan hart- en vaatziekte en andere complicaties. Nierdisfunctie veroorzaakt uremie, ontsteking, oxidatieve stress, hormonale ontregelingen, anorexie en dysbiose. Inname van calorieën, vezels, proteïne, fosfaat, calcium, kalium, magnesium, vitamine D en vitamine K moet goed op elkaar afgestemd worden. Dit overzicht heeft enkel betrekking op niet-dialytische nierpatiënten.

Beste bezoeker, u heeft geen toegang.

Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.

U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!

Auteur

Joost Meeusen

Trefwoorden:

Verschenen in

Referenties

  1. Kalantar-Zadeh K, Tortorici AR et al. Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial. 2015 Mar-Apr;28(2):159-68

  2. Anderson CA, Nguyen HA, Rifkin DE. Nutrition interventions in chronic kidney disease. Med Clin North Am. 2016 Nov;100(6):1265-1283. doi: 10.1016/j.mcna.2016.06.008. Epub 2016 Sep 13.

  3. Alhosaini M, Leehey DJ. Magnesium and dialysis: the neglected cation. Am J Kidney Dis. 2015 Sep;66(3):523-31

  4. DASH (Dietary Approaches to Stop Hypertension) diet and risk of subsequent kidney disease. Am J Kidney Dis. 2016;68(6):853-861

  5. Gallieni M, Cupisti A. DASH and mediterranean diets as nutritional interventions for CKD patients. Am J Kidney Dis. 2016 Dec;68(6):828-830.

  6. el Nahas AM, Coles GA. Dietary treatment of chronic renal failure: ten unanswered questions. Lancet. 1986 Mar 15;1(8481):597-600

  7. Piccoli GB, Capizzi I, Vigotti FN et al. Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines? BMC Nephrol. 2016 Jul 8;17(1):76

  8. Shah BV, Patel ZM. Role of low protein diet in management of different stages of chronic kidney disease - practical aspects. BMC Nephrol. 2016 Oct 21;17(1):156

  9. Bellizzi V, Cupisti A, Locatelli F et al. Low-protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrol. 2016 Jul 11;17(1):77

  10. Watanabe S. Low-protein diet for the prevention of renal failure. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(1):1-9

  11. Wiederkehr M, Krapf R. Metabolic and endocrine effects of metabolic acidosis in humans. Swiss Med Wkly. 2001 Mar 10;131(9-10):127-32

  12. Di Iorio BR, Di Micco L, Marzocco S et al. Very low-protein diet (VLPD) reduces metabolic acidosis in subjects with chronic kidney disease: The "Nutritional Light Signal" of the renal acid load. Nutrients. 2017 Jan 17;9(1). pii: E69

  13. Schwingshackl L, Hoffmann G. Comparison of high vs. normal/low protein diets on renal function in subjects without chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2014 May 22;9(5):e97656

  14. Jiang Z, Zhang X et al. Effect of restricted protein diet supplemented with keto analogues in chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol. 2016 Mar;48(3):409-18

  15. Vanholder R, Fouque D, Glorieux G et al. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol. 2016 Apr;4(4):360-73

  16. Kovesdy CP, Kalantar-Zadeh K. Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health. Int Urol Nephrol. 2016 May;48(5):725-9

  17. Chan M, Kelly J, Batterham M, Tapsell L. A high prevalence of abnormal nutrition parameters found in predialysis end-stage kidney disease: is it a result of uremia or poor eating habits? J Ren Nutr. 2014 Sep;24(5):292-302

  18. Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol. 2015 Nov;47(11):1801-7

  19. Hirai K, Ookawara S, Morishita Y. Sarcopenia and physical inactivity in patients with chronic kidney disease. Nephrourol Mon. 2016 Apr 26;8(3):e37443

  20. Kittiskulnam P, Carrero JJ, Chertow GM et al. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2016 Aug 11. doi: 10.1002/jcsm.12130

  21. Jing Z, Wei-Jie Y. Effects of soy protein containing isoflavones in patients with chronic kidney disease: A systematic review and meta-analysis. Clin Nutr. 2016 Feb;35(1):117-24

  22. Kuczera P, Adamczak M, Wiecek A. Fibroblast Growth Factor-23-A Potential Uremic Toxin. Toxins (Basel). 2016 Dec 8;8(12). pii: E369

  23. Langman CB, Cannata-Andía JB. Calcium in chronic kidney disease: myths and realities. Introduction. Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S1-2

  24. Isakova T, Ix JH, Sprague SM et al. Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD. J Am Soc Nephrol. 2015 Oct;26(10):2328-39

  25. Taketani Y, Koiwa F, Yokoyama K. Management of phosphorus load in CKD patients. Clin Exp Nephrol. 2017 Mar;21(Suppl 1):27-36

  26. Cannata-Andía JB, Martin KJ. The challenge of controlling phosphorus in chronic kidney disease. Nephrol Dial Transplant. 2016 Apr;31(4):541-7

  27. Kalaitzidis RG, Duni A, Siamopoulos KC. Klotho, the Holy Grail of the kidney: from salt sensitivity to chronic kidney disease. Int Urol Nephrol. 2016 Oct;48(10):1657-66

  28. Neyra JA, Hu MC. Potential application of klotho in human chronic kidney disease. Bone. 2017 Jan 20. pii: S8756-3282(17)30017-0

  29. El Borolossy R, El Wakeel LM et al. Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis. Pediatr Nephrol. 2016 Feb;31(2):289-96

  30. Teo HK, Wong J. Unusual cause of hypercalcaemia in end stage renal failure patients. Hemodial Int. 2016 Nov 20. doi: 10.1111/hdi.12512

  31. Liu WC, Wu CC, Hung YM et al. Pleiotropic effects of vitamin D in chronic kidney disease. Clin Chim Acta. 2016 Jan 30;453:1-12

  32. Weiner DE, Kapoian T, Johnson DS. Nutrition, vitamin D, and health outcomes in hemodialysis: time for a feeding frenzy? Curr Opin Nephrol Hypertens. 2015 Nov;24(6):546-56

  33. McCabe KM, Adams MA, Holden RM. Vitamin K status in chronic kidney disease. Nutrients. 2013 Nov 7;5(11):4390-8

  34. Kurnatowska I, Grzelak P, Masajtis-Zagajewska A et al. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5. Pol Arch Med Wewn. 2015;125(9):631-40

  35. Shigematsu T, Sonou T et al. Preventive strategies for vascular calcification in patients with chronic kidney disease. Contrib Nephrol. 2017;189:169-177

  36. Chen Z, Qureshi AR, Parini P et al. Does statins promote vascular calcification in chronic kidney disease? Eur J Clin Invest. 2017 Feb;47(2):137-148. doi: 10.1111/eci.12718

  37. Genovesi S, Gallieni M. Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks? Expert Opin Drug Saf. 2014 Sep;13(9):1143-8

  38. Chiavaroli L, Mirrahimi A et al. Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2015 Jul;69(7):761-8

  39. Salmean YA, Segal MS, Palii SP et al. Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients. J Ren Nutr. 2015 May;25(3):316-20

  40. Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney disease. Kidney Int. 2015 Nov;88(5):958-66

  41. Nallu A, Sharma S, Ramezani A et al. Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res. 2017 Jan;179:24-37

  42. Rhee EP, Clish CB, Ghorbani A et al. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol. 2013 Jul;24(8):1330-8

  43. Ramezani A, Massy ZA et al. Role of the gut microbiome in uremia: A potential therapeutic target. Am J Kidney Dis. 2016 Mar;67(3):483-98

  44. Ikizler TA. Nutrition, inflammation and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008 Mar;17(2):162-7

  45. Gondouin B, Jourde-Chiche N, Sallee M et al. Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels. Nephron. 2015;131(3):167-74

  46. Krishnamurthy A, Lazaro D, Stefanov DG et al. The effect of allopurinol on renal function. J Clin Rheumatol. 2017 Jan;23(1):1-5

  47. Clarke RE, Dordevic AL, Tan SM et al. Dietary advanced glycation end products and risk factors for chronic disease: A systematic review of randomised controlled trials. Nutrients. 2016 Mar 1;8(3):125

  48. Meeusen J. Advanced glycation endproducts. Waarom suiker toxisch is. Arts Therapeut & Apotheker. 2011;12(2)

  49. Jalal DI, Chonchol M, Chen W et al. Uric acid as a target of therapy in CKD. Am J Kidney Dis. 2013 Jan;61(1):134-46

  50. Coombes JS, Fassett RG. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int. 2012 Feb;81(3):233-46

  51. Daud ZA, Tubie B, Sheyman M et al. Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vasc Health Risk Manag. 2013;9:747-61

  52. Himmelfarb J, Ikizler TA, Ellis C et al. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol. 2014 Mar;25(3):623-33

  53. Ramos LF, Kane J, McMonagle E et al. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr. 2011 May;21(3):211-8

  54. Himmelfarb J, Phinney S et al. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr. 2007 Sep;17(5):296-304

  55. Sahebkar A, Cicero AF et al. Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016 May;107:234-42

  56. Derosa G, Maffioli P et al. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016 Sep;111:394-404.

  57. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res. 2014 May;28(5):633-42

  58. Saboori S, Shab-Bidar S, Speakman JR et al. Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2015 Aug;69(8):867-73

  59. Sahni N, Gupta KL, Rana SV et al. Intake of antioxidants and their status in chronic kidney disease patients. J Ren Nutr. 2012 Jul;22(4):389-99

  60. L Gupta K, Sahni N. Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients. J Nephropathol. 2012 Oct;1(3):134-42

  61. Jun M, Venkataraman V, Razavian M et al. Antioxidants for chronic kidney disease. Cochrane Database Syst Rev. 2012 Oct 17;10:CD008176

  62. Dupont JJ, Farquhar WB, Townsend RR et al. Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol (1985). 2011 Dec;111(6):1561-7

  63. Sabri MR, Tavana EN, Ahmadi A et al. Effect of vitamin C on endothelial function of children with chronic renal failure: An experimental study. Adv Biomed Res. 2015 Dec 31;4:260

  64. Ruiz S, Pergola PE, Zager RA et al. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013 Jun;83(6):1029-41

  65. Saran R, Novak JE, Desai A et al. Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study. Nephrol Dial Transplant. 2003 Nov;18(11):2415-20

  66. Mas E, Barden A, Burke V et al. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. Clin Nutr. 2016 Apr;35(2):331-6

  67. Barden AE, Burke V, Mas E et al. n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease. Hypertens. 2015 Sep;33(9):1947-53

  68. Cupisti A, D'Alessandro C, Fumagalli G et al. Nutrition and physical activity in CKD patients. Kidney Blood Press Res. 2014;39(2-3):107-13

  69. Moinuddin I, Leehey DJ. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis. 2008 Jan;15(1):83-96

  70. Webster A, Palmer S et al. Statins for chronic kidney disease not requiring dialysis. Nephrology (Carlton). 2015 Apr;20(4):300-1

  71. Sharma S, McFann K, Chonchol M et al. Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study. Am J Nephrol. 2013;37(6):526-33

  72. Sarafidis PA, Georgianos PI, Bakris GL. Advances in treatment of hyperkalemia in chronic kidney disease. Expert Opin Pharmacother. 2015;16(14):2205-15

  73. Wang HH, Hung CC, Hwang DY et al. Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease. PLoS One. 2013 Jul 2;8(7):e67140

  74. Humalda JK, Navis G. Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens. 2014 Nov;23(6):533-40

  75. McMahon EJ, Bauer JD et al. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013 Dec;24(12):2096-103

  76. van Zuilen AD, Bots ML, Dulger A et al. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int. 2012 Sep;82(6):710-7

  77. M de Francisco AL1, Rodríguez M. Magnesium - its role in CKD. Nefrologia. 2013;33(3):389-99

  78. Dousdampanis P, Trigka K, Fourtounas C. Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation. Hemodial Int. 2014 Oct;18(4):730-9

  79. Kanbay M1, Goldsmith D, Uyar ME et al. Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif. 2010;29(3):280-92

  80. Javed RA, Marrero K, Rafique M et al. Life-threatening hyperkalaemia developing following excessive ingestion of orange juice in a patient with baseline normal renal function. Singapore Med J. 2007 Nov;48(11):e293-5

  81. Palmer BF, Clegg DJ. Achieving the benefits of a high-potassium, paleolithic diet, without the toxicity. Mayo Clin Proc. 2016 Apr;91(4):496-508

  82. Rebholz CM, Coresh J, Grams ME et al. Dietary acid load and incident chronic kidney disease: Results from the ARIC Study. Am J Nephrol. 2015;42(6):427-35

  83. Tanemoto M, Ishimoto Y, Saito H. Oral low-dose ferric citrate is a useful iron source for hyperphosphatemic hemodialysis patients: a case series. Blood Purif. 2016 Dec 13;43(1-3):97-100

  84. Fishbane S, Block GA et al. Effects of ferric citrate in patients with nondialysis-dependent CKD and iron deficiency anemia. J Am Soc Nephrol. 2017 Jan 12. pii: ASN.2016101053

  85. Block GA, Fishbane S, Rodriguez M et al. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. Am J Kidney Dis. 2015 May;65(5):728-36

  86. Katai K, Iwamoto A, Kimura Y et al. Wakame (Undaria pinnatifida ) modulates hyperphosphatemia in a rat model of chronic renal failure. J Med Invest. 2015;62(1-2):68-74

  87. Zhang X, Lerman LO. The metabolic syndrome and chronic kidney disease. Transl Res. 2016 Dec 9. pii: S1931-5244(16)30424-8

  88. Lobo JC, Aranha LN, Moraes C et al. Linking zinc and leptin in chronic kidney disease: future directions. Biol Trace Elem Res. 2012 Apr;146(1):1-5

  89. Takahashi N, Morimoto S, Okigaki M et al. Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients. Nephrol Dial Transplant. 2011 Apr;26(4):1252-7

  90. Timmer S. Vegetarisme oké, maar veganisme? Arts Therapeut & Apotheker. 2016; 17(1)

  91. Muskiet F. Eten we teveel zout (natrium)? Een holistische kijk op onze Na-K-Ca-Mg en zuur/base balans. Ned Tijdschr Klin Chem Labgeneesk 2015; 40: 164-193

Gerelateerde artikelen

Magnesium en vitamine B6 verminderen beide stress
Mycoproteïne beter voor spieropbouw dan melk
Calcium verlaagt opname van lycopeen
Hema
Geen risico op nierstenen door hoge dosis vitamine D